TECH up +0.88% percent right now. $TECH High is at 92.07

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
TECH up +0.88% percent right now. $TECH High is at 92.07 and the Low 90.30 with current volume of 59,771.

Recent News posted below.

TECH Techne Corp Recent Headline News

Techne on an Acquisition Spree, Buys CyVek for $60M - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 05, 5:41PM CST
Techne Corp. (TECH) intends to leverage CyPlex, CyVek's breakthrough technology to derive maximum value from its extensive reagents portfolio.
GE: 26.33 (-0.14), BDX: 128.58 (+0.28), TMO: 117.77 (+0.92), TECH: 91.31 (+0.21)

Ex-Dividend Alert: 3 Stocks Going Ex-Dividend Tomorrow: CHY, TECH, EXH
at The Street - Wed Nov 05, 9:53AM CST
CHY TECH EXH are going ex-dividend tomorrow, Thursday, November 06, 2014
EXH: 34.48 (+0.08), CHY: 14.51 (+0.15), TECH: 91.31 (+0.21)

Techne Corp. (TECH) Q1 Earnings, Revenues Miss Estimates - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 12:50PM CST
Techne Corp. (TECH) reported adjusted earnings of 85 cents per share in the first quarter fiscal 2015, which was lower than the Zacks Consensus Estimate of 87 cents.
CYNO: 25.91 (+0.50), FLDM: 29.46 (+0.46), TECH: 91.31 (+0.21), ANGO: 16.95 (-0.01)

Bio-Techne Announces Agreement To Acquire CyVek
PR Newswire - Tue Nov 04, 6:00AM CST
Bio-Techne Corporation (NASDAQ: TECH) announced today that it has agreed to acquire CyVek, Inc. (CyVek) for $60 million in cash, plus a potential earn-out payment of up to $35 million based on CyVek revenue over the 30-month period following the closing and an additional potential earn-out payment based on CyVek revenue through 2020 in excess of $100 million. The closing of the acquisition is the result of CyVek having met pre-agreed commercial milestones. The transaction will be financed through a combination of cash on hand and a revolving line of credit facility.
TECH: 91.31 (+0.21)

Techne's board to pay dividend to holders of record of 10 November 2014
M2 - Fri Oct 31, 6:53AM CDT
The board of directors of Techne (NasdaqGS:TECH), a life science company, on Thursday declared its dividend of USD0.32 per share of its common stock for the quarter ended 30 September 2014.
TECH: 91.31 (+0.21)

Techne Corporation declares $0.32 dividend
Seeking Alpha - at Seeking Alpha - Thu Oct 30, 4:51PM CDT

TECH: 91.31 (+0.21)

Bio-Techne Declares Dividend
PR Newswire - Thu Oct 30, 3:01PM CDT
Techne Corporation (NASDAQ:TECH), (d/b/a Bio-Techne) announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended September 30, 2014. The quarterly dividend will be payable November 24, 2014 to all common shareholders of record on November 10, 2014. Future cash dividends will be considered by the Board of Directors on a quarterly basis.
TECH: 91.31 (+0.21)

Techne Corp ups revenues 27% in FQ1
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 1:26PM CDT

TECH: 91.31 (+0.21)

Techne's (TECH) CEO, Charles Kummeth on Q1 2015 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Oct 28, 11:17AM CDT

TECH: 91.31 (+0.21)

Techne misses by $0.02, misses on revenue
Seeking Alpha - at Seeking Alpha - Tue Oct 28, 5:25AM CDT

TECH: 91.31 (+0.21)

Techne misses Street 1Q forecasts
Automated Insights - Tue Oct 28, 5:22AM CDT
MINNEAPOLIS (AP) _ Techne Corp. (TECH) on Tuesday reported fiscal first-quarter net income of $23.9 million.
TECH: 91.31 (+0.21)

Bio-Techne Releases First Quarter Fiscal 2015 Results
PR Newswire - Tue Oct 28, 5:00AM CDT
Techne Corporation (NASDAQ:TECH), (d/b/a Bio-Techne) today reported its financial results for the first quarter ended September 30, 2014.
TECH: 91.31 (+0.21)

Bio-Techne To Host Conference Call On October 28, 2014 To Announce First Quarter Financial Results
PR Newswire - Tue Oct 21, 7:00AM CDT
Techne Corporation (NASDAQ:TECH), d/b/a Bio-Techne, today announced that management will host a conference call on Tuesday, October 28, 2014, at 8:00 a.m. CDT to review first quarter fiscal 2015 financial results.
TECH: 91.31 (+0.21)

Dividend Challengers (And Near-Challengers): 57 Increases Expected By New Year's Day
David Fish - at Seeking Alpha - Sat Oct 18, 5:51PM CDT

RKT: 55.84 (-0.25), TTC: 62.94 (-0.01), HST: 22.69 (-0.07), OCR: 69.10 (+0.37), HI: 34.46 (+0.04), MAIN: 32.22 (-0.03), MHLD: 12.60 (+0.15), PRU: 86.12 (-0.42), DEI: 27.85 (-0.68), PSA: 187.89 (-0.23), THG: 69.15 (-0.08), KKR: 21.73 (-0.11), RL: 170.69 (-1.23), VTR: 68.50 (-0.11), AEP: 57.90 (-0.48), EVR: 50.91 (-0.77), TECH: 91.31 (+0.21), ROK: 112.58 (-0.17), INGR: 79.95 (-0.61), WTI: 9.45 (+0.55), COR: 37.85 (unch), EXL: 12.90 (-0.12), UG: 19.23 (+0.23), BGS: 28.79 (-0.81), ESV: 39.36 (-0.56), APTS: 8.71 (-0.03), EL: 72.64 (-0.19), HEI: 53.12 (-1.30), GE: 26.33 (-0.14), BOKF: 67.98 (-0.66), SNA: 135.45 (-0.31), BCPC: 68.80 (+3.07), SBUX: 77.70 (+0.05), V: 249.17 (-1.04), KIM: 24.78 (-0.16), BBSI: 23.03 (-1.25), SIX: 40.21 (+0.28), EMCI: 33.21 (+0.06), CHS: 15.14 (+0.08), NEU: 389.31 (-0.66), BMR: 21.59 (-0.06), EMN: 84.23 (+0.39), PRA: 44.97 (-0.17), CBL: 18.98 (-0.42), CUBE: 20.99 (-0.11), DIS: 89.68 (-0.10), BMY: 58.73 (-0.08), ABC: 88.02 (+0.31), RCII: 31.64 (-0.03), WCN: 50.33 (-0.01), HCI: 44.02 (+0.11), MAC: 69.25 (-0.30), AMTD: 35.22 (+0.16), HUB.B: 112.48 (+0.68), JCI: 49.45 (+0.28)

Techne-Comm archiving solutions supports NHSmail refresh
M2 - Tue Oct 07, 9:04AM CDT
Techne-Comm, an email filing and archiving specialist, is gaining momentum within the healthcare sector with its archiving solution Mailsafe, as various units within the NHS adopt NHSmail.
TECH: 91.31 (+0.21)

Techne Upped to Buy on Solid Fiscal Q4 & Accretive Buyouts - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Aug 19, 4:00PM CDT
Techne has been enjoying rising estimate revisions in the past 7 days with five upward revisions and no downward revision for fiscal 2015.
ATEC: 1.44 (+0.02), RTIX: 4.98 (-0.13), TECH: 91.31 (+0.21), ERB: 2.94 (+0.20)

Techne Fiscal Q4 Earnings Beat Estimates; Shares Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Aug 13, 9:30AM CDT
Techne Corp. (TECH) posted a 7.3% rise in adjusted earnings per share to 88 cents for the fourth quarter fiscal 2014 (ended Jun 30, 2014) from 82 cents in the year-ago quarter.
ATEC: 1.44 (+0.02), RTIX: 4.98 (-0.13), BONE: 4.07 (-0.02), TECH: 91.31 (+0.21)

Bio-Techne Releases Fourth Quarter And Full Year 2014 Results
PR Newswire - Mon Aug 11, 6:00AM CDT
Techne Corporation (NASDAQ:TECH), (d/b/a Bio-Techne) today reported its financial results for the fourth quarter and full year ended June 30, 2014.
TECH: 91.31 (+0.21)

Bio-Techne Announces Appointment Of Brenda Furlow As General Counsel
PR Newswire - Mon Aug 04, 4:00PM CDT
Techne Corporation (NASDAQ: TECH) (d/b/a Bio-Techne), a leading global provider of life science reagents and clinical controls, announces the appointment of Brenda S. Furlow as Senior Vice President and General Counsel effective August 4, 2014. Ms. Furlow is a legal executive with experience in several globally diverse technology businesses, and has a broad understanding of the legal issues facing technology companies in today's complex legal environment. Ms. Furlow will be responsible for legal and compliance matters for Bio-Techne and its affiliates.
TECH: 91.31 (+0.21)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 239

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 154

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 0

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 170

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Spooky Dining at CARNE: A Halloween Hit in Oxnard

Updated Category News Views 158

A Festive Transformation at CARNE Rolling into Oxnard, you're met with an unconventional dining spectacle at CARNE. It's not your average restaurant fare as they've pulled out the stops with their spirited Halloween pop-up, A Nightmare at CARNE. Channeling the eerie charm of "The Nightmare Before Christmas," this temporary transformation morphs the venue into a lively,...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 184

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 328

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 141

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Senator Whitehouse Addresses Challenges in Climate Summit Attendance

Updated Category News Views 330

Senator Whitehouse's Message on Climate Action Sen. Sheldon Whitehouse emphasized a direct message at this year's U.N. climate summit. He assured global negotiators that the United States remains dedicated to climate action, despite the challenges faced during the Trump administration. Challenges at the U.N. Climate Summit Whitehouse specifically pointed out internal...

Continue Reading
The Surge of Spearmint Oil: Insights on Market Growth to 2033

Updated Category News Views 125

Growing Potential of the Spearmint Oil Market Allied Market Research has revealed exciting projections for the spearmint oil market, anticipating it will escalate from a valuation of $180.1 million in recent years to an impressive $377.5 million by 2033, all the while attaining a compound annual growth rate (CAGR) of 7.7% from 2024 to 2033. Factors Fueling Market...

Continue Reading
Exploring Adobe's Stock Growth Track Record Over Two Decades

Updated Category News Views 212

Adobe Stock: A 20-Year Investment Journey Adobe Inc (NASDAQ: ADBE) has demonstrated exceptional stock performance over the past twenty years, consistently outpacing market averages by 5.02% annually. This remarkable growth culminates in an average annual return of 13.66%, showcasing the strength of Adobe’s business model and innovative contributions to the tech...

Continue Reading
Virginia Housing Program Expands Access with New Limits

Updated Category News Views 187

Virginia Housing Introduces New Income and Sales Price Limits Recently, Virginia Housing announced significant updates regarding the maximum gross household income and sales price limits for homebuyers. This change is destined to benefit numerous first-time and repeat homebuyers across the state of Virginia. With these updates, a wider range of individuals and families...

Continue Reading
DraftKings Poised for Strong Growth in Revenue and Earnings

Updated Category News Views 219

Analysts Optimistic About DraftKings' Future Growth DraftKings Inc (NASDAQ: DKNG) is garnering attention as analysts assess the company's outlook for 2025 following its recent fourth-quarter results. Industry experts are weighing in on the potential for substantial growth in revenue and earnings, indicating a positive trajectory for the company. Strong Analyst Ratings...

Continue Reading